Simulations Plus, Inc. (NASDAQ:SLP) Director Walter S. Woltosz Sells 20,000 Shares of Stock

Simulations Plus, Inc. (NASDAQ:SLPGet Free Report) Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction on Monday, April 1st. The stock was sold at an average price of $39.94, for a total transaction of $798,800.00. Following the sale, the director now owns 3,600,195 shares of the company’s stock, valued at $143,791,788.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Simulations Plus Price Performance

NASDAQ SLP opened at $38.60 on Wednesday. The company has a market capitalization of $770.84 million, a PE ratio of 72.83 and a beta of 0.72. The company has a fifty day moving average of $41.33 and a 200 day moving average of $40.39. Simulations Plus, Inc. has a 1 year low of $32.69 and a 1 year high of $52.69.

Simulations Plus (NASDAQ:SLPGet Free Report) last posted its earnings results on Wednesday, January 3rd. The technology company reported $0.10 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.10. The company had revenue of $14.50 million during the quarter, compared to the consensus estimate of $13.94 million. Simulations Plus had a net margin of 17.12% and a return on equity of 8.18%. The firm’s quarterly revenue was up 21.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.06 earnings per share. Research analysts expect that Simulations Plus, Inc. will post 0.67 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Craig Hallum lifted their price objective on shares of Simulations Plus from $50.00 to $51.00 and gave the stock a “buy” rating in a research note on Thursday, January 4th.

Get Our Latest Report on Simulations Plus

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. PNC Financial Services Group Inc. lifted its position in Simulations Plus by 36.8% during the fourth quarter. PNC Financial Services Group Inc. now owns 11,426 shares of the technology company’s stock valued at $511,000 after purchasing an additional 3,072 shares during the period. Vanguard Group Inc. raised its position in shares of Simulations Plus by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 1,122,469 shares of the technology company’s stock worth $50,230,000 after acquiring an additional 3,591 shares during the period. Price T Rowe Associates Inc. MD raised its position in shares of Simulations Plus by 17.3% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 9,486 shares of the technology company’s stock worth $425,000 after acquiring an additional 1,397 shares during the period. Barclays PLC raised its position in shares of Simulations Plus by 20,036.3% in the fourth quarter. Barclays PLC now owns 24,969 shares of the technology company’s stock worth $1,118,000 after acquiring an additional 24,845 shares during the period. Finally, Nuveen Asset Management LLC raised its position in shares of Simulations Plus by 1.3% in the fourth quarter. Nuveen Asset Management LLC now owns 47,067 shares of the technology company’s stock worth $2,106,000 after acquiring an additional 585 shares during the period. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Simulations Plus Company Profile

(Get Free Report)

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.

Featured Articles

Insider Buying and Selling by Quarter for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.